Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation.

chemoselective ligation cysteine mutagenesis glycoconjugate vaccine pneumococcal vaccine protein conjugation thio/maleimide ligation

Journal

Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988

Informations de publication

Date de publication:
2019
Historique:
received: 28 07 2019
accepted: 10 10 2019
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 19 11 2019
Statut: epublish

Résumé

Glycoconjugate vaccines are formed by covalently link a carbohydrate antigen to a carrier protein whose role is to achieve a long lasting immune response directed against the carbohydrate antigen. The nature of the sugar antigen, its length, its ratio per carrier protein and the conjugation chemistry impact on both structure and the immune response of a glycoconjugate vaccine. In addition it has long been assumed that the sites at which the carbohydrate antigen is attached can also have an impact. These important issue can now be addressed owing to the development of novel chemoselective ligation reactions as well as techniques such as site-selective mutagenesis, glycoengineering, or extension of the genetic code. The preparation and characterization of homogeneous bivalent pneumococcal vaccines is reported. The preparation and characterization of homogeneous bivalent pneumococcal vaccines is reported. A synthetic tetrasaccharide representative of the serotype 14 capsular polysaccharide of

Identifiants

pubmed: 31737603
doi: 10.3389/fchem.2019.00726
pmc: PMC6839274
doi:

Types de publication

Journal Article

Langues

eng

Pagination

726

Informations de copyright

Copyright © 2019 Pillot, Defontaine, Fateh, Lambert, Prasanna, Fanuel, Pipelier, Csaba, Violo, Camberlein and Grandjean.

Références

J Am Chem Soc. 2018 Mar 21;140(11):4004-4017
pubmed: 29473744
Vaccine. 2011 May 23;29(23):3982-9
pubmed: 21481328
Chem Soc Rev. 2018 Dec 10;47(24):9015-9025
pubmed: 30277489
Infect Immun. 2012 Jan;80(1):461-8
pubmed: 22025519
Immunobiology. 2010 Jul;215(7):545-50
pubmed: 19880214
Vaccine. 2015 Jan 3;33(2):314-20
pubmed: 25448110
Vaccine. 2017 Dec 18;35(51):7181-7186
pubmed: 29132988
PLoS One. 2016 Aug 15;11(8):e0161257
pubmed: 27526117
Infect Immun. 2002 Sep;70(9):5107-14
pubmed: 12183560
Immunol Invest. 2015;44(5):482-96
pubmed: 26107747
Nat Chem Biol. 2014 Jan;10(1):35-41
pubmed: 24212134
Front Immunol. 2017 Jun 02;8:659
pubmed: 28626461
Biol Direct. 2011 Feb 09;6:9
pubmed: 21306646
J Immunol. 1989 Apr 1;142(7):2464-8
pubmed: 2784464
ACS Chem Biol. 2015 Jul 17;10(7):1737-46
pubmed: 25906283
Angew Chem Int Ed Engl. 2015 Nov 2;54(45):13198-203
pubmed: 26350581
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5194-7
pubmed: 10220442
Eur J Pharm Sci. 2019 Mar 1;129:31-41
pubmed: 30572107
Immunology. 2014 Apr;141(4):514-30
pubmed: 24138116
Front Med. 2016 Dec;10(4):490-498
pubmed: 27650380
Chembiochem. 2018 Apr 16;19(8):805-814
pubmed: 29377518
PLoS Pathog. 2017 Dec 21;13(12):e1006665
pubmed: 29267378
Hybridoma. 2000 Feb;19(1):23-31
pubmed: 10768838
Structure. 1998 Dec 15;6(12):1553-61
pubmed: 9862808
Vaccine. 2006 Apr 12;24(16):3224-31
pubmed: 16487631
Annu Rev Immunol. 1995;13:655-92
pubmed: 7612238
Infect Immun. 2010 Jul;78(7):3258-71
pubmed: 20479086
Chembiochem. 2014 Apr 14;15(6):836-43
pubmed: 24616190
Bioconjug Chem. 2014 Dec 17;25(12):2105-11
pubmed: 25415860
Angew Chem Int Ed Engl. 2011 Apr 26;50(18):4127-32
pubmed: 21455919
BMC Infect Dis. 2018 Aug 29;18(1):440
pubmed: 30157780
Protein Expr Purif. 2011 Jul;78(1):38-47
pubmed: 21362478
Infect Immun. 2008 Oct;76(10):4615-23
pubmed: 18678667
Vaccine. 2010 Apr 19;28(18):3071-5
pubmed: 20206671
Oncotarget. 2017 Jun 30;9(1):75-82
pubmed: 29416597
Sci Transl Med. 2018 Aug 29;10(456):
pubmed: 30158151
Bioconjug Chem. 2015 Oct 21;26(10):2167
pubmed: 26355285
J Clin Invest. 1972 Jan;51(1):89-96
pubmed: 4621363
Nat Rev Immunol. 2009 Mar;9(3):213-20
pubmed: 19214194
Microb Pathog. 2008 Mar;44(3):186-96
pubmed: 17997274
Crit Rev Microbiol. 2008;34(3-4):131-42
pubmed: 18728990
J Infect Dis. 2002 Feb 15;185(4):489-96
pubmed: 11865401
Nat Med. 2011 Nov 20;17(12):1602-9
pubmed: 22101769
FEBS Lett. 2015 Jul 8;589(15):1703-12
pubmed: 25937125
ACS Chem Biol. 2013 Aug 16;8(8):1653-63
pubmed: 23841819

Auteurs

Aline Pillot (A)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.
Université de Nantes, CNRS, Chimie Et Interdisciplinarité: Synthèse, Analyse, Modélisation (CEISAM), UMR 6230, Nantes, France.

Alain Defontaine (A)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Amina Fateh (A)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Annie Lambert (A)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Maruthi Prasanna (M)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.
Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), School of Pharamacy, Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain.

Mathieu Fanuel (M)

Unité Biopolymères Interactions Assemblages Plate-Forme BIBS, INRA, Nantes, France.

Muriel Pipelier (M)

Université de Nantes, CNRS, Chimie Et Interdisciplinarité: Synthèse, Analyse, Modélisation (CEISAM), UMR 6230, Nantes, France.

Noemi Csaba (N)

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), School of Pharamacy, Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain.

Typhaine Violo (T)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Emilie Camberlein (E)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Cyrille Grandjean (C)

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 6286, Nantes, France.

Classifications MeSH